-+ 0.00%
-+ 0.00%
-+ 0.00%
SYNCONA shares rose 6.1% after the company announced that BEACON THERAPEUTICS had positive top-line results in the Phase II/III VISTA trial.
Share
Listen to the news
SYNCONA shares rose 6.1% after the company announced that BEACON THERAPEUTICS had positive top-line results in the Phase II/III VISTA trial.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending